SEC 13F Intelligence

Birchview Capital, LP / PACB

Birchview Capital, LP’s Pacific Biosciences Calif In Position

Does Birchview Capital, LP own Pacific Biosciences Calif In (PACB)? Yes — 1.50M shares worth $2M (+1.13% of its 13F portfolio) as of Q1 2026, up from 500.0K shares the prior filed quarter.

Position Value
$2M
Q1 2026
Shares
1.50M
% of Portfolio
+1.13%
Quarters Held
4
currently held

Position History PACB

Reported value by quarter
Q2 ’25: $496,000Q2 ’25Q3 ’25: $640,000Q3 ’25Q4 ’25: $935,000Q4 ’25Q1 ’26: $2MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.50M$2M+1.13%
Q4 2025500.0K$935,000+0.55%
Q3 2025500.0K$640,000+0.48%
Q2 2025400.0K$496,000+0.49%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Birchview Capital, LP’s full portfolio or all institutional holders of PACB.